Following years in development, Finnish medtech GlucoModicum has unveiled its needle-free glucose monitoring patch, designed as a temporary reader for people with Type 2 diabetes who do not need ...
Comprehensive clinical performance study encompassed 646 participant visits, including both Type 2 diabetic patients and healthy volunteers Magnetohydrodynamic (MHD) technology achieves 11.5% MARD in ...
Fully automated, ultra-high-volume line providing sub-second cycle time, medical-grade precision, and scalable capacity of 21 million units per year. Mpac Lambert’s expertise in high-volume and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results